4547
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Kissei Pharmaceutical Co., Ltd. is a pharmaceutical company that researches, develops, manufactures, and sells medical drugs, including healthcare foods and special purpose foods. The company operates through four main business segments: Pharmaceuticals, which involves the production and distribution of its own drugs and the procurement of third-party pharmaceuticals; Goods Sales, conducted through Kissei Shoji, which develops and sells noodles centered on Shinshu soba, equipment, vehicles, and fuel, and acts as an insurance agent; Information Services, managed by Kissei Comtech, providing system integration, resource services such as network construction and equipment rental, and medical system development; and Construction & Facility Maintenance, executed by Hashiba Technos, offering comprehensive construction and facility management services. Kissei America, Inc. supports the group by collecting and analyzing overseas drug development information and facilitating outsourced research activities.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - General Homepage kissei.co.jp
Sector Healthcare IR page kissei.co.jp
Tags
pharmaceuticals, medical drugs, healthcare foods, noodle manufacturing, insurance agency, system integration, medical systems, construction services, facility maintenance, KISSEI AMERICA INC., Kissei Shoji, Kissei Comtech, Hashiba Technos
Press page kissei.co.jp/news

Metrics

Valuation  
Market cap ¥ 173.834B
Market cap (USD) $ 1.086B
P/E 13.85
PEG 1.48
P/BV 0.76
P/S 1.79
P/OCF -19.43
P/FCF -12.33
Dividend yield 4.3%
Turnover / mcap —
Returns  
ROE 6.2%
ROI 5.9%
ROIC -1.0%
Profit margin 14.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 9.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 4
Quality score 16.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 97.406B 88.33B 75.579B 67.493B 65.381B 69.044B 63.234B 72.297B 74.009B 71.706B 71.294B 70.11B 70.399B 62.491B
Net profit 13.779B 11.961B 11.16B 10.528B 12.921B 5.285B 2.817B 5.481B 9.045B 7.726B 8.165B 7.165B 9.093B 5.019B
Free cash flow -7.121B 1.491B -3.51B -9.226B 44M -4.027B 12.632B 5.013B 6.725B 3.909B 3.482B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 4.641K 3.837K 3.528K 2.646K 2.551K 2.448K 2.781K 2.896K 2.878K 2.92K 2.59K 3.748K 2.561K 1.981K
Price performance 12m 0.21 0.09 0.33 0.04 0.04 -0.12 -0.04 0.01 -0.01 0.13 -0.31 0.46 0.29 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 24.7B 28.9B 27B 19.5B 23.1B 22B 22.1B 27.8B 29B 30.8B
↳ YoY growth -0.9% +16.8% -6.6% -27.8% +18.5% -4.8% +0.6% +25.8% +4.2% +6.3%
↳ 5y CAGR -1.6% -2.4% -5.2% +0.6% +8.3% +5.9%
Borrowings, current (JPY) 1.8B 1.76B 1.76B 1.75B 1.74B 1.64B 1.49B 1.34B 1.28B 1.25B
Borrowings, non-current (JPY) 1.66B 1.88B 1.93B 13M — — — — — —
Cash and deposits (JPY) 27.1B 24.4B 26.3B 36.3B 20.5B 30B 25.9B 22.9B 25.2B 29.1B
Intangible assets (JPY) 1.85B 1.72B 1.52B 1.51B 1.64B 1.57B 1.51B 1.99B 1.89B 1.97B
Net debt (borrowings + leases - cash) (JPY) -23.7B -20.7B -22.6B -34.6B -18.7B -28.4B -24.4B -21.6B -23.9B -27.8B
Cash flow detail
Operating cash flow (JPY) 6.44B 8.85B 6.35B 13.9B -2.54B 1.53B -6.68B -1.68B 6.52B -1.49B
Purchases of property, plant and equipment (JPY) -1.2B -1.87B -1.09B -879M -931M -1.49B -2.1B -1.2B -4.51B -4.88B
Purchases of intangible assets (JPY) -1.33B -253M -240M -423M -554M -430M -444M -632M -523M -753M
Change in receivables (cash effect) (JPY) 236M -4.14B 1.91B 7.5B -3.6B — — — — —
Change in inventories (cash effect) (JPY) 650M 793M 1.97B 525M -6.68B 1.13B -3.81B -3.48B 1.32B -542M
Change in payables (cash effect) (JPY) -979M 44M -546M 890M 2.67B -3.8B 513M 275M -291M 2.06B
Dividends paid (cash effect) (JPY) -2.2B -2.27B -2.29B -2.38B -2.48B -2.54B -3.14B -3.72B -3.8B -4.84B
Share buybacks (cash effect) (JPY) -1.65B -4.46B 0.00 0.00 -1.3B 0.00 0.00 -6B -5.29B -5.22B
Interest paid (cash effect) (JPY) -24M -23M -23M -23M -23M -23M -20M -18M -22M -29M
Income taxes paid (cash effect) (JPY) -3.41B -2.45B -4.02B -1.05B -652M -2.57B -5.7B -1.83B -4.36B -3.36B
Operating cash flow before change in receivables (JPY) 6.21B 13B 4.44B 6.43B 1.05B — — — — —
Free cash flow (OCF - PPE - intangibles) (JPY) 3.91B 6.73B 5.01B 12.6B -4.03B -386M -9.23B -3.51B 1.49B -7.12B
Income detail
Research and development expense (JPY) 13.9B 14.2B 15.7B 10.8B 9.63B 10.4B 10.4B 9.47B 12.9B 22.5B
↳ 5y CAGR -7.4% -5.7% -6.0% -9.6% +3.7% +18.5%
Total comprehensive income (JPY) 3.51B 25B 8.9B 12.6B 30.8B -13.8B -4.23B 36B -1.91B 31.4B
Comprehensive income to owners (JPY) 3.46B 25B 8.85B 12.6B 30.6B -13.9B -4.35B 35.9B -1.93B 31.1B
Provision for credit losses (JPY) — — — — — — 15M — — —
Credit cost ratio (credit losses / average receivables) (%) — — — — — — 0.1% — — —
Segments
Construction And Facility Maintenance Business · Segment revenue (JPY) — — — — — — — 4.92B 5.99B 7.38B
↳ YoY growth +21.8% +23.3%
Construction And Facility Maintenance Business · Segment operating income (JPY) — — — — — — — 261M 460M 595M
Construction Contracting · Segment revenue (JPY) — — 5.21B 4.71B 4.64B 4.33B 3.28B 4.92B — —
↳ YoY growth -9.6% -1.4% -6.6% -24.4% +50.1%
Construction Contracting · Segment operating income (JPY) — — 176M 275M 309M 192M 78M 261M — —
Trading Business · Segment revenue (JPY) — — 2.99B 2.89B 1.96B 763M 824M 983M 1.07B 1.14B
↳ YoY growth -3.3% -32.4% -61.0% +8.0% +19.3% +8.6% +6.5%
Trading Business · Segment operating income (JPY) — — 41M 29M -10M 30M 21M 81M 99M 136M
Reported Jun 28, 2017 Jun 27, 2018 Jun 26, 2020 Jun 26, 2020 Jun 24, 2021 Jun 23, 2022 Jun 22, 2023 Jun 24, 2025 Jun 24, 2025 Jun 22, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Kissei Pharmaceutical Co., Ltd. (ticker 4547), listed in Japan.

ETFs Holding Kissei Pharmaceutical Co., Ltd.

ETF Weight in ETF Shares Market value As of
AVDS 0.03% 3,800 $ 92.926K Nov 16, 2026
AVDE 0.00% 2,200 $ 53.799K Nov 16, 2026